Stock RTGN RETINALGENIX TECHNOLOGIES INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News RetinalGenix Technologies Inc.

Equities

RTGN

US76133Y1055

Market Closed - OTC Markets
Other stock markets
 12:47:02 2024-02-22 pm EST 		5-day change 1st Jan Change
3.5 USD +12.90% Intraday chart for RetinalGenix Technologies Inc. -.--% +13.27%
Apr. 01 RetinalGenix Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Feb. 09 RetinalGenix Technologies Inc. announced that it has received $4.65 million in funding CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
RetinalGenix Technologies Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
RetinalGeniX™ Technologies Inc. Granted a Patent for System And Method For Visualization Of Ocular Anatomy
GL
RetinalGeniX™ Technologies Inc. Granted a Patent for System And Method For Visualization Of Ocular Anatomy
AQ
RetinalGenix Technologies Inc. announced that it has received $4.65 million in funding
CI
RetinalGenix Technologies Inc. announced that it expects to receive $4.65 million in funding
CI
RetinalGeniX™ Technologies Inc. Contracts With MEDsan, Inc. to Provide Diagnostic Testing Services for Its Institutional Review Board to Conduct a Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration
GL
RetinalGeniX?? Technologies Inc. Contracts with Medsan, Inc. to Provide Diagnostic Testing Services for Its Institutional Review Board to Conduct a Study to Personalize Medical Evaluations for Patients Receiving Treatment for Wet Macular Degeneration
CI
RetinalGeniX Technologies Inc. Appoints Anatoly Dritschilo, M.D. to the Company’s Medical Advisory Board
GL
RetinalGeniX Technologies Inc. Appoints Anatoly Dritschilo, M.D. to the Company’s Medical Advisory Board
AQ
RetinalGeniX Technologies Inc. Appoints Anatoly Dritschilo, M.D. to the Medical Advisory Board
CI
RetinalGeniX Technologies Inc. Appoints Dessy Boneva, MD, FACS to the Board of Directors
GL
RetinalGeniX Technologies Inc. Appoints Dessy Boneva, MD, FACS to the Board of Directors
AQ
RetinalGeniX Technologies Inc. Appoints Dessislava Boneva to its Board of Directors
CI
RetinalGeniX Technologies Inc. Announces Hiring of Interim CFO
GL
RetinalGenix Technologies Inc. Appoints Virender Ahluwalia as Interim Chief Financial Officer
CI
RetinalGeniX Technologies Inc. Appoints Stephen Tannenbaum to the Company's Business Advisory Board
GL
RetinalGeniX Technologies Inc. Appoints Stephen Tannenbaum to the Company's Business Advisory Board
AQ
RetinalGenix Technologies Inc. Appoints Stephen Tannenbaum to the Business Advisory Board
CI
RetinalGenix Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
RetinalGeniX™ Technologies Inc. Announces the Submission of Two Provisional Patent Applications For Investigational Therapeutic Drugs
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RTGN Stock
  4. News RetinalGenix Technologies Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW